[A case report of idiopathic hypogonadotropic hypogonadism with particular reference to monitoring of prostate volume].
A 23-year-old man visited our hospital, complaining of a lack of secondary sexual characteristics. Based on both clinical and endocrinological examinations, he was diagnosed as suffering from idiopathic hypogonadotropic hypogonadism (IHH). With human chorionic gonadotropin (hCG)/human menopausal gonadotropin (hMG) replacement therapy, clinical symptoms and serum testosterone levels improved to normal ranges. Interestingly, prostate volume as measured by transrectal ultrasonography increased considerably from 3.6 ml before treatment to 20.2 ml after treatment. The monitoring of prostate volume might be a parameter useful for evaluating the treatment effect of hCG/hMG replacement therapy in IHH.
Hirayama
Kifu
K
Department of Urology, Nagoya Urology Hospital.
Okada
Koichi
K
Kanemitsu
Noriyuki
N
Kojima
Munekado
M
Hayase
Yosimasa
Y
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006062:Gonadotropins / Q000097:blood*; D006801:Humans; D007006:Hypogonadism / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008596:Menotropins / Q000008:administration & dosage*; D011467:Prostate / Q000000981:diagnostic imaging*; D013739:Testosterone / Q000097:blood; D014463:Ultrasonography
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D013739:Testosterone; D008596:Menotropins